Northwestern Mutual Wealth Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-500	Closed	-$6K	–	2653
2016 Q4	$6K	Buy	+500	New	+$6.02K	﹤0.01%	1821
2016 Q3	–	Sell	-500	Closed	-$4K	–	1944
2016 Q2	$4K	Buy	+500	New	+$3.75K	﹤0.01%	1713
2015 Q4	–	Sell	-405	Closed	-$2K	–	2003
2015 Q3	$2K	Buy	+405	New	+$3.12K	﹤0.01%	1504

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's ARIA Position: Q1 2017 in Review

Northwestern Mutual Wealth Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 500 shares — an estimated $6K sold.

Northwestern Mutual Wealth Management first reported a position in ARIA in Q3 2015 and held it in 3 quarters. The position peaked at $6K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Northwestern Mutual Wealth Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 500 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $6K.
Northwestern Mutual Wealth Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2015 and held it in 3 quarters.
Northwestern Mutual Wealth Management's Ariad Pharmaceuticals Inc position peaked at $6K in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.